Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BGD Salvage Therapy and ASCT in Advanced Classical Hodgkin Lymphoma
NCT03615664Phase 2Completed
- Sponsor
- Polish Lymphoma Research Group
- Start
- Nov 2017
- Primary completion
- Nov 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine, gemcitabine, dexamethasone in classical Hodgkin lymphoma (cHL), sponsored by Polish Lymphoma Research Group. Started Nov 2017; status: completed.
02
Drugs
bendamustinegemcitabinedexamethasone
03
Conditions
classical Hodgkin lymphoma (cHL)
Beyond the preview
Go deeper on NCT03615664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03615664.